nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Sepsis—Methotrexate—lymphatic system cancer	0.000805	0.000805	CcSEcCtD
Gabapentin—Agitation—Carmustine—lymphatic system cancer	0.000805	0.000805	CcSEcCtD
Gabapentin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000801	0.000801	CcSEcCtD
Gabapentin—Asthenia—Fludarabine—lymphatic system cancer	0.000801	0.000801	CcSEcCtD
Gabapentin—Rash—Teniposide—lymphatic system cancer	0.000801	0.000801	CcSEcCtD
Gabapentin—Dermatitis—Teniposide—lymphatic system cancer	0.0008	0.0008	CcSEcCtD
Gabapentin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000797	0.000797	CcSEcCtD
Gabapentin—Headache—Teniposide—lymphatic system cancer	0.000796	0.000796	CcSEcCtD
Gabapentin—Pruritus—Fludarabine—lymphatic system cancer	0.00079	0.00079	CcSEcCtD
Gabapentin—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000789	0.000789	CcSEcCtD
Gabapentin—Back pain—Mitoxantrone—lymphatic system cancer	0.000787	0.000787	CcSEcCtD
Gabapentin—Leukopenia—Carmustine—lymphatic system cancer	0.000784	0.000784	CcSEcCtD
Gabapentin—Anorexia—Bleomycin—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Gabapentin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000778	0.000778	CcSEcCtD
Gabapentin—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000774	0.000774	CcSEcCtD
Gabapentin—Anaemia—Vincristine—lymphatic system cancer	0.000772	0.000772	CcSEcCtD
Gabapentin—Agitation—Vincristine—lymphatic system cancer	0.000768	0.000768	CcSEcCtD
Gabapentin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000767	0.000767	CcSEcCtD
Gabapentin—Polyuria—Methotrexate—lymphatic system cancer	0.000767	0.000767	CcSEcCtD
Gabapentin—Hypotension—Bleomycin—lymphatic system cancer	0.000765	0.000765	CcSEcCtD
Gabapentin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000764	0.000764	CcSEcCtD
Gabapentin—Convulsion—Carmustine—lymphatic system cancer	0.000759	0.000759	CcSEcCtD
Gabapentin—Hypertension—Carmustine—lymphatic system cancer	0.000756	0.000756	CcSEcCtD
Gabapentin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000755	0.000755	CcSEcCtD
Gabapentin—Nausea—Teniposide—lymphatic system cancer	0.000755	0.000755	CcSEcCtD
Gabapentin—Anaemia—Mitoxantrone—lymphatic system cancer	0.000752	0.000752	CcSEcCtD
Gabapentin—Vertigo—Vincristine—lymphatic system cancer	0.000751	0.000751	CcSEcCtD
Gabapentin—Hepatic failure—Methotrexate—lymphatic system cancer	0.000749	0.000749	CcSEcCtD
Gabapentin—Leukopenia—Vincristine—lymphatic system cancer	0.000748	0.000748	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000746	0.000746	CcSEcCtD
Gabapentin—Chest pain—Carmustine—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Gabapentin—Myalgia—Carmustine—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Gabapentin—Anxiety—Carmustine—lymphatic system cancer	0.000743	0.000743	CcSEcCtD
Gabapentin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000735	0.000735	CcSEcCtD
Gabapentin—Malaise—Mitoxantrone—lymphatic system cancer	0.000734	0.000734	CcSEcCtD
Gabapentin—Dyspnoea—Bleomycin—lymphatic system cancer	0.00073	0.00073	CcSEcCtD
Gabapentin—Renal failure acute—Methotrexate—lymphatic system cancer	0.000729	0.000729	CcSEcCtD
Gabapentin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000729	0.000729	CcSEcCtD
Gabapentin—Convulsion—Vincristine—lymphatic system cancer	0.000724	0.000724	CcSEcCtD
Gabapentin—Hypertension—Vincristine—lymphatic system cancer	0.000722	0.000722	CcSEcCtD
Gabapentin—Confusional state—Carmustine—lymphatic system cancer	0.00072	0.00072	CcSEcCtD
Gabapentin—Oedema—Carmustine—lymphatic system cancer	0.000715	0.000715	CcSEcCtD
Gabapentin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000712	0.000712	CcSEcCtD
Gabapentin—Myalgia—Vincristine—lymphatic system cancer	0.000712	0.000712	CcSEcCtD
Gabapentin—Cough—Mitoxantrone—lymphatic system cancer	0.00071	0.00071	CcSEcCtD
Gabapentin—Infection—Carmustine—lymphatic system cancer	0.00071	0.00071	CcSEcCtD
Gabapentin—Vomiting—Fludarabine—lymphatic system cancer	0.00071	0.00071	CcSEcCtD
Gabapentin—Convulsion—Mitoxantrone—lymphatic system cancer	0.000705	0.000705	CcSEcCtD
Gabapentin—Rash—Fludarabine—lymphatic system cancer	0.000704	0.000704	CcSEcCtD
Gabapentin—Dermatitis—Fludarabine—lymphatic system cancer	0.000703	0.000703	CcSEcCtD
Gabapentin—Hypertension—Mitoxantrone—lymphatic system cancer	0.000703	0.000703	CcSEcCtD
Gabapentin—Pain—Bleomycin—lymphatic system cancer	0.0007	0.0007	CcSEcCtD
Gabapentin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.0007	0.0007	CcSEcCtD
Gabapentin—Headache—Fludarabine—lymphatic system cancer	0.000699	0.000699	CcSEcCtD
Gabapentin—Tachycardia—Carmustine—lymphatic system cancer	0.000697	0.000697	CcSEcCtD
Gabapentin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000693	0.000693	CcSEcCtD
Gabapentin—Chest pain—Mitoxantrone—lymphatic system cancer	0.000693	0.000693	CcSEcCtD
Gabapentin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000693	0.000693	CcSEcCtD
Gabapentin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000691	0.000691	CcSEcCtD
Gabapentin—Lethargy—Methotrexate—lymphatic system cancer	0.000687	0.000687	CcSEcCtD
Gabapentin—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000687	0.000687	CcSEcCtD
Gabapentin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000685	0.000685	CcSEcCtD
Gabapentin—Oedema—Vincristine—lymphatic system cancer	0.000682	0.000682	CcSEcCtD
Gabapentin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000682	0.000682	CcSEcCtD
Gabapentin—Anorexia—Carmustine—lymphatic system cancer	0.000681	0.000681	CcSEcCtD
Gabapentin—Infection—Vincristine—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Gabapentin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000675	0.000675	CcSEcCtD
Gabapentin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000673	0.000673	CcSEcCtD
Gabapentin—Confusional state—Mitoxantrone—lymphatic system cancer	0.00067	0.00067	CcSEcCtD
Gabapentin—Nervous system disorder—Vincristine—lymphatic system cancer	0.000669	0.000669	CcSEcCtD
Gabapentin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000668	0.000668	CcSEcCtD
Gabapentin—Hypotension—Carmustine—lymphatic system cancer	0.000668	0.000668	CcSEcCtD
Gabapentin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000664	0.000664	CcSEcCtD
Gabapentin—Oedema—Mitoxantrone—lymphatic system cancer	0.000664	0.000664	CcSEcCtD
Gabapentin—Nausea—Fludarabine—lymphatic system cancer	0.000663	0.000663	CcSEcCtD
Gabapentin—Infection—Mitoxantrone—lymphatic system cancer	0.00066	0.00066	CcSEcCtD
Gabapentin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000659	0.000659	CcSEcCtD
Gabapentin—Shock—Mitoxantrone—lymphatic system cancer	0.000654	0.000654	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000651	0.000651	CcSEcCtD
Gabapentin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00065	0.00065	CcSEcCtD
Gabapentin—Urticaria—Bleomycin—lymphatic system cancer	0.00065	0.00065	CcSEcCtD
Gabapentin—Anorexia—Vincristine—lymphatic system cancer	0.00065	0.00065	CcSEcCtD
Gabapentin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000648	0.000648	CcSEcCtD
Gabapentin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000647	0.000647	CcSEcCtD
Gabapentin—Insomnia—Carmustine—lymphatic system cancer	0.000646	0.000646	CcSEcCtD
Gabapentin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000645	0.000645	CcSEcCtD
Gabapentin—Irritability—Methotrexate—lymphatic system cancer	0.000643	0.000643	CcSEcCtD
Gabapentin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000642	0.000642	CcSEcCtD
Gabapentin—Paraesthesia—Carmustine—lymphatic system cancer	0.000642	0.000642	CcSEcCtD
Gabapentin—Mood swings—Methotrexate—lymphatic system cancer	0.000638	0.000638	CcSEcCtD
Gabapentin—Hypotension—Vincristine—lymphatic system cancer	0.000637	0.000637	CcSEcCtD
Gabapentin—Dyspnoea—Carmustine—lymphatic system cancer	0.000637	0.000637	CcSEcCtD
Gabapentin—Somnolence—Carmustine—lymphatic system cancer	0.000635	0.000635	CcSEcCtD
Gabapentin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000633	0.000633	CcSEcCtD
Gabapentin—Ataxia—Methotrexate—lymphatic system cancer	0.000633	0.000633	CcSEcCtD
Gabapentin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000622	0.000622	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000621	0.000621	CcSEcCtD
Gabapentin—Decreased appetite—Carmustine—lymphatic system cancer	0.000621	0.000621	CcSEcCtD
Gabapentin—Hypotension—Mitoxantrone—lymphatic system cancer	0.000621	0.000621	CcSEcCtD
Gabapentin—Insomnia—Vincristine—lymphatic system cancer	0.000617	0.000617	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000617	0.000617	CcSEcCtD
Gabapentin—Paraesthesia—Vincristine—lymphatic system cancer	0.000612	0.000612	CcSEcCtD
Gabapentin—Pain—Carmustine—lymphatic system cancer	0.000611	0.000611	CcSEcCtD
Gabapentin—Constipation—Carmustine—lymphatic system cancer	0.000611	0.000611	CcSEcCtD
Gabapentin—Breast disorder—Methotrexate—lymphatic system cancer	0.000608	0.000608	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000605	0.000605	CcSEcCtD
Gabapentin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000603	0.000603	CcSEcCtD
Gabapentin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000596	0.000596	CcSEcCtD
Gabapentin—Decreased appetite—Vincristine—lymphatic system cancer	0.000593	0.000593	CcSEcCtD
Gabapentin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000592	0.000592	CcSEcCtD
Gabapentin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000591	0.000591	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000589	0.000589	CcSEcCtD
Gabapentin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000589	0.000589	CcSEcCtD
Gabapentin—Fatigue—Vincristine—lymphatic system cancer	0.000588	0.000588	CcSEcCtD
Gabapentin—Asthenia—Bleomycin—lymphatic system cancer	0.000587	0.000587	CcSEcCtD
Gabapentin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000585	0.000585	CcSEcCtD
Gabapentin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000584	0.000584	CcSEcCtD
Gabapentin—Constipation—Vincristine—lymphatic system cancer	0.000583	0.000583	CcSEcCtD
Gabapentin—Pain—Vincristine—lymphatic system cancer	0.000583	0.000583	CcSEcCtD
Gabapentin—Asthma—Methotrexate—lymphatic system cancer	0.000582	0.000582	CcSEcCtD
Gabapentin—Pruritus—Bleomycin—lymphatic system cancer	0.000579	0.000579	CcSEcCtD
Gabapentin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000577	0.000577	CcSEcCtD
Gabapentin—Eosinophilia—Methotrexate—lymphatic system cancer	0.000576	0.000576	CcSEcCtD
Gabapentin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000573	0.000573	CcSEcCtD
Gabapentin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000571	0.000571	CcSEcCtD
Gabapentin—Pain—Mitoxantrone—lymphatic system cancer	0.000568	0.000568	CcSEcCtD
Gabapentin—Constipation—Mitoxantrone—lymphatic system cancer	0.000568	0.000568	CcSEcCtD
Gabapentin—Abdominal pain—Carmustine—lymphatic system cancer	0.000565	0.000565	CcSEcCtD
Gabapentin—Body temperature increased—Carmustine—lymphatic system cancer	0.000565	0.000565	CcSEcCtD
Gabapentin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000558	0.000558	CcSEcCtD
Gabapentin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000547	0.000547	CcSEcCtD
Gabapentin—Dysuria—Methotrexate—lymphatic system cancer	0.000544	0.000544	CcSEcCtD
Gabapentin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000543	0.000543	CcSEcCtD
Gabapentin—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000541	0.000541	CcSEcCtD
Gabapentin—Abdominal pain—Vincristine—lymphatic system cancer	0.000539	0.000539	CcSEcCtD
Gabapentin—Body temperature increased—Vincristine—lymphatic system cancer	0.000539	0.000539	CcSEcCtD
Gabapentin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000536	0.000536	CcSEcCtD
Gabapentin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000531	0.000531	CcSEcCtD
Gabapentin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000528	0.000528	CcSEcCtD
Gabapentin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000526	0.000526	CcSEcCtD
Gabapentin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000525	0.000525	CcSEcCtD
Gabapentin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000525	0.000525	CcSEcCtD
Gabapentin—Pneumonia—Methotrexate—lymphatic system cancer	0.000522	0.000522	CcSEcCtD
Gabapentin—Vomiting—Bleomycin—lymphatic system cancer	0.00052	0.00052	CcSEcCtD
Gabapentin—Infestation—Methotrexate—lymphatic system cancer	0.000519	0.000519	CcSEcCtD
Gabapentin—Infestation NOS—Methotrexate—lymphatic system cancer	0.000519	0.000519	CcSEcCtD
Gabapentin—Drowsiness—Methotrexate—lymphatic system cancer	0.000519	0.000519	CcSEcCtD
Gabapentin—Depression—Methotrexate—lymphatic system cancer	0.000517	0.000517	CcSEcCtD
Gabapentin—Rash—Bleomycin—lymphatic system cancer	0.000516	0.000516	CcSEcCtD
Gabapentin—Dermatitis—Bleomycin—lymphatic system cancer	0.000516	0.000516	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000514	0.000514	CcSEcCtD
Gabapentin—Asthenia—Carmustine—lymphatic system cancer	0.000513	0.000513	CcSEcCtD
Gabapentin—Renal failure—Methotrexate—lymphatic system cancer	0.00051	0.00051	CcSEcCtD
Gabapentin—Stomatitis—Methotrexate—lymphatic system cancer	0.000506	0.000506	CcSEcCtD
Gabapentin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000504	0.000504	CcSEcCtD
Gabapentin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000503	0.000503	CcSEcCtD
Gabapentin—Sweating—Methotrexate—lymphatic system cancer	0.000497	0.000497	CcSEcCtD
Gabapentin—Haematuria—Methotrexate—lymphatic system cancer	0.000495	0.000495	CcSEcCtD
Gabapentin—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000491	0.000491	CcSEcCtD
Gabapentin—Epistaxis—Methotrexate—lymphatic system cancer	0.000489	0.000489	CcSEcCtD
Gabapentin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000489	0.000489	CcSEcCtD
Gabapentin—Asthenia—Vincristine—lymphatic system cancer	0.000489	0.000489	CcSEcCtD
Gabapentin—Diarrhoea—Carmustine—lymphatic system cancer	0.000489	0.000489	CcSEcCtD
Gabapentin—Nausea—Bleomycin—lymphatic system cancer	0.000486	0.000486	CcSEcCtD
Gabapentin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000477	0.000477	CcSEcCtD
Gabapentin—Dizziness—Carmustine—lymphatic system cancer	0.000472	0.000472	CcSEcCtD
Gabapentin—Diarrhoea—Vincristine—lymphatic system cancer	0.000467	0.000467	CcSEcCtD
Gabapentin—Hepatitis—Methotrexate—lymphatic system cancer	0.000466	0.000466	CcSEcCtD
Gabapentin—Haemorrhage—Methotrexate—lymphatic system cancer	0.000466	0.000466	CcSEcCtD
Gabapentin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000462	0.000462	CcSEcCtD
Gabapentin—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00046	0.00046	CcSEcCtD
Gabapentin—Urethral disorder—Methotrexate—lymphatic system cancer	0.000457	0.000457	CcSEcCtD
Gabapentin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000454	0.000454	CcSEcCtD
Gabapentin—Vomiting—Carmustine—lymphatic system cancer	0.000454	0.000454	CcSEcCtD
Gabapentin—Dizziness—Vincristine—lymphatic system cancer	0.000451	0.000451	CcSEcCtD
Gabapentin—Rash—Carmustine—lymphatic system cancer	0.000451	0.000451	CcSEcCtD
Gabapentin—Dermatitis—Carmustine—lymphatic system cancer	0.00045	0.00045	CcSEcCtD
Gabapentin—Visual impairment—Methotrexate—lymphatic system cancer	0.000449	0.000449	CcSEcCtD
Gabapentin—Headache—Carmustine—lymphatic system cancer	0.000448	0.000448	CcSEcCtD
Gabapentin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00044	0.00044	CcSEcCtD
Gabapentin—Eye disorder—Methotrexate—lymphatic system cancer	0.000435	0.000435	CcSEcCtD
Gabapentin—Tinnitus—Methotrexate—lymphatic system cancer	0.000434	0.000434	CcSEcCtD
Gabapentin—Vomiting—Vincristine—lymphatic system cancer	0.000434	0.000434	CcSEcCtD
Gabapentin—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000432	0.000432	CcSEcCtD
Gabapentin—Rash—Vincristine—lymphatic system cancer	0.00043	0.00043	CcSEcCtD
Gabapentin—Dermatitis—Vincristine—lymphatic system cancer	0.00043	0.00043	CcSEcCtD
Gabapentin—Headache—Vincristine—lymphatic system cancer	0.000427	0.000427	CcSEcCtD
Gabapentin—Nausea—Carmustine—lymphatic system cancer	0.000424	0.000424	CcSEcCtD
Gabapentin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000422	0.000422	CcSEcCtD
Gabapentin—Immune system disorder—Methotrexate—lymphatic system cancer	0.000421	0.000421	CcSEcCtD
Gabapentin—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00042	0.00042	CcSEcCtD
Gabapentin—Rash—Mitoxantrone—lymphatic system cancer	0.000419	0.000419	CcSEcCtD
Gabapentin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000418	0.000418	CcSEcCtD
Gabapentin—Chills—Methotrexate—lymphatic system cancer	0.000418	0.000418	CcSEcCtD
Gabapentin—Headache—Mitoxantrone—lymphatic system cancer	0.000416	0.000416	CcSEcCtD
Gabapentin—Alopecia—Methotrexate—lymphatic system cancer	0.000412	0.000412	CcSEcCtD
Gabapentin—Mental disorder—Methotrexate—lymphatic system cancer	0.000408	0.000408	CcSEcCtD
Gabapentin—Malnutrition—Methotrexate—lymphatic system cancer	0.000406	0.000406	CcSEcCtD
Gabapentin—Erythema—Methotrexate—lymphatic system cancer	0.000406	0.000406	CcSEcCtD
Gabapentin—Nausea—Vincristine—lymphatic system cancer	0.000405	0.000405	CcSEcCtD
Gabapentin—Dysgeusia—Methotrexate—lymphatic system cancer	0.000397	0.000397	CcSEcCtD
Gabapentin—Nausea—Mitoxantrone—lymphatic system cancer	0.000395	0.000395	CcSEcCtD
Gabapentin—Back pain—Methotrexate—lymphatic system cancer	0.000392	0.000392	CcSEcCtD
Gabapentin—Vision blurred—Methotrexate—lymphatic system cancer	0.000382	0.000382	CcSEcCtD
Gabapentin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000376	0.000376	CcSEcCtD
Gabapentin—Anaemia—Methotrexate—lymphatic system cancer	0.000375	0.000375	CcSEcCtD
Gabapentin—Malaise—Methotrexate—lymphatic system cancer	0.000366	0.000366	CcSEcCtD
Gabapentin—Vertigo—Methotrexate—lymphatic system cancer	0.000364	0.000364	CcSEcCtD
Gabapentin—Leukopenia—Methotrexate—lymphatic system cancer	0.000363	0.000363	CcSEcCtD
Gabapentin—Cough—Methotrexate—lymphatic system cancer	0.000354	0.000354	CcSEcCtD
Gabapentin—Convulsion—Methotrexate—lymphatic system cancer	0.000351	0.000351	CcSEcCtD
Gabapentin—Myalgia—Methotrexate—lymphatic system cancer	0.000345	0.000345	CcSEcCtD
Gabapentin—Arthralgia—Methotrexate—lymphatic system cancer	0.000345	0.000345	CcSEcCtD
Gabapentin—Chest pain—Methotrexate—lymphatic system cancer	0.000345	0.000345	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000343	0.000343	CcSEcCtD
Gabapentin—Discomfort—Methotrexate—lymphatic system cancer	0.000341	0.000341	CcSEcCtD
Gabapentin—Confusional state—Methotrexate—lymphatic system cancer	0.000334	0.000334	CcSEcCtD
Gabapentin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000331	0.000331	CcSEcCtD
Gabapentin—Infection—Methotrexate—lymphatic system cancer	0.000329	0.000329	CcSEcCtD
Gabapentin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000325	0.000325	CcSEcCtD
Gabapentin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000324	0.000324	CcSEcCtD
Gabapentin—Skin disorder—Methotrexate—lymphatic system cancer	0.000321	0.000321	CcSEcCtD
Gabapentin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00032	0.00032	CcSEcCtD
Gabapentin—Anorexia—Methotrexate—lymphatic system cancer	0.000315	0.000315	CcSEcCtD
Gabapentin—Hypotension—Methotrexate—lymphatic system cancer	0.000309	0.000309	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000302	0.000302	CcSEcCtD
Gabapentin—Insomnia—Methotrexate—lymphatic system cancer	0.000299	0.000299	CcSEcCtD
Gabapentin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000297	0.000297	CcSEcCtD
Gabapentin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000295	0.000295	CcSEcCtD
Gabapentin—Somnolence—Methotrexate—lymphatic system cancer	0.000294	0.000294	CcSEcCtD
Gabapentin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000291	0.000291	CcSEcCtD
Gabapentin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000288	0.000288	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000286	0.000286	CcSEcCtD
Gabapentin—Fatigue—Methotrexate—lymphatic system cancer	0.000285	0.000285	CcSEcCtD
Gabapentin—Pain—Methotrexate—lymphatic system cancer	0.000283	0.000283	CcSEcCtD
Gabapentin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000273	0.000273	CcSEcCtD
Gabapentin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000271	0.000271	CcSEcCtD
Gabapentin—Urticaria—Methotrexate—lymphatic system cancer	0.000263	0.000263	CcSEcCtD
Gabapentin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000262	0.000262	CcSEcCtD
Gabapentin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000262	0.000262	CcSEcCtD
Gabapentin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000244	0.000244	CcSEcCtD
Gabapentin—Asthenia—Methotrexate—lymphatic system cancer	0.000237	0.000237	CcSEcCtD
Gabapentin—Pruritus—Methotrexate—lymphatic system cancer	0.000234	0.000234	CcSEcCtD
Gabapentin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000226	0.000226	CcSEcCtD
Gabapentin—Dizziness—Methotrexate—lymphatic system cancer	0.000219	0.000219	CcSEcCtD
Gabapentin—Vomiting—Methotrexate—lymphatic system cancer	0.00021	0.00021	CcSEcCtD
Gabapentin—Rash—Methotrexate—lymphatic system cancer	0.000209	0.000209	CcSEcCtD
Gabapentin—Dermatitis—Methotrexate—lymphatic system cancer	0.000208	0.000208	CcSEcCtD
Gabapentin—Headache—Methotrexate—lymphatic system cancer	0.000207	0.000207	CcSEcCtD
Gabapentin—Nausea—Methotrexate—lymphatic system cancer	0.000197	0.000197	CcSEcCtD
